Therefore, direct assessment of TFAM’s ability to initiate mtDNA transcription and replication (as performed by Karamanlidis and colleagues [62]) is among the next important steps in understanding why mtDNA copy number and oxidative capacity are low in COPD muscle. The gene discussed is TFAM; the disease is chronic obstructive pulmonary disease.